Madrigal Diagnosed With Shoulder Fracture; Manaea To Begin Season On IL With Oblique Strain

Mets infielder Nick Madrigal has been diagnosed with a fracture in his left shoulder after undergoing an MRI, manager Carlos Mendoza announced to the team’s beat this morning (via Anthony DiComo of MLB.com). He’ll be out “for a long time,” per Mendoza, though a formal timeline isn’t yet established. Madrigal is headed for a CT scan for further evaluation. Mendoza also revealed that left-hander Sean Manaea has a right oblique strain that will shut him down for the next couple weeks, likely ticketing him for the injured list to begin the season (via Newsday’s Tim Healey).

Madrigal’s injury occurred while playing shortstop during yesterday’s spring contest against the Nationals. The former top prospect charged a grounder that kicked off the mound, making a barehanded play and falling to the ground as he threw to first base (video link via MLB.com). Commentary noted that Madrigal headed straight for the dugout upon getting up, so it’s clear he knew something was amiss right away. He was originally diagnosed with a dislocated shoulder, but imaging revealed the fracture that will shelve him for a considerable period.

The Mets inked Madrigal to a split major league contract that paid him at a $1.35MM rate in the majors. The former No. 4 overall pick has a minor league option remaining and might’ve been bound for Triple-A to begin the year, but he’ll presumably head to the major league 60-day IL whenever the Mets next need a roster spot instead. He wasn’t expected to have a starting role, with Francisco Lindor and Jeff McNeil lined up in the middle infield and Mark Vientos at third base, but a strong camp would likely have put Madrigal in line for a bench role.

Instead, the Mets will presumably tap into their upper-minors depth. Brett Baty, Ronny Mauricio and Luisangel Acuña have all drawn top-100 fanfare at various points in recent seasons. Baty isn’t an option to back up at shortstop, however, and Mauricio is still on the mend from the ACL tear that cost him the entire 2024 season. He’s not expected to play in spring games until mid-March. Acuña, who made his big league debut late last year, seems the likeliest in-house candidate to step into Madrigal’s spot.

It’s possible that the long-term nature of the injury could prompt the Mets to look outside the organization, where fan and clubhouse favorite Jose Iglesias remains unsigned. The Mets all but announced they were moving on from Iglesias a couple weeks back, with president of baseball operations David Stearns noting a lack of roster flexibility at the time.

Signing Iglesias would give the Mets a bench full of players who cannot be optioned to Triple-A. Catcher Luis Torrens and outfielder Tyrone Taylor have both exhausted their slate of minor league options, while Starling Marte can’t be optioned without his consent — as is his right as a player with five-plus years of major league service time. Iglesias would be in that same boat. In the event of an Iglesias signing, the only position player on the Mets’ roster who could be optioned would be Francisco Alvarez, who’s obviously not at risk of being sent down.

The loss of Manaea, meanwhile, further thins out a rotation that will see Frankie Montas shelved by a lat strain to begin the season. That takes two members out of the Opening Day rotation, which now likely includes a combination of Kodai Senga, David Peterson, Clay Holmes, Paul Blackburn, Griffin Canning and Tylor Megill. It’s not a formidable group, with health and workload questions permeating the entire staff.

That said, the Mets weren’t planning to add another starter after losing Montas to a longer-term injury than the one Manaea currently faces. Montas will likely be sidelined into mid-May at the earliest. Manaea could very plausibly return in April if he rehabs the oblique issue without any setbacks. The immediate outcry among many Mets fans on social media was to use the Manaea injury as the impetus to re-sign Jose Quintana, but Will Sammon of The Athletic reports that the Mets are still planning to stick with in-house options.

On the one hand, it’s sensible enough that a short-term Manaea absence won’t prompt what would surely be an eight-figure expenditure after factoring in luxury taxes. Signing Quintana, Kyle Gibson, Lance Lynn or another veteran hurler for the full season when Manaea could miss as few as three to four starts in April could be construed as an overreaction.

On the other, the Mets quite arguably didn’t do enough with their rotation this winter in the first place. Senga pitched in one game last year due to injuries. Montas’ 2023 was wiped out by shoulder surgery, and he posted a 4.84 ERA over 150 innings in last year’s return. Holmes is converting to the rotation after six years pitching exclusively as a reliever. Canning was non-tendered and has a 4.96 ERA over his past three seasons. Blackburn is a fourth/fifth starter who was limited to 75 innings by a spinal injury last year. The rotation lacks certainty even when it’s at full strength — and the Mets are a ways off from full strength as things stand.